by GMFH Editing Team
Imbalances in the gut microbiota composition have been described as a hallmark of certain liver diseases. Yi Duan from the University of California San Diego and colleagues have found in mice that specific phages targeting the gut-dwelling bacterium E. faecalis might be used to treat patients with alcoholic hepatitis.
Consuming probiotics is beneficial for treating metabolic diseases such as obesity, diabetes and non-alcoholic fatty liver disease, which are a global health problem.
by Researchers from the Univ. of Toledo-Microbiome Consortium
A recent study published by researchers from the University of Toledo, in Cell, raises a health concern about that these refined soluble fibers.
by GMFH Editing Team
Bernd Schnabl is an Associate Professor in Gastroenterology at University of California San Diego School of Medicine, where he investigates precisely the pathogenesis of chronic liver disease. He attended the 5th Gut Microbiota for Health World Summit 2016.
